Neonatal management of a child exposed to tobacco in utero and postnatal biomarkers;Quelle est la prise en charge optimale à la naissance de l'enfant exposé au tabac in utero et quels en sont les biomarqueurs post-natals?

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue SPEC. ISS. 1, 2005, Pages

  Diguet, A ^a   Sentilhes, L ^a   Marret, S ^a   Verspyck, E ^a   Marpeau, L ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Biomarkers; Management; Newborn; Nicotine; Perinatal outcome; Tobacco

Indexed keywords

BIOLOGICAL MARKER; CARBON DIOXIDE; COTININE;

CARBON DIOXIDE MEASUREMENT; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEWBORN; NEWBORN CARE; PERINATAL MORBIDITY; PERINATAL MORTALITY; PERINATAL PERIOD; PREMATURITY; RELIABILITY; SMOKING; UMBILICAL CORD; CHEMICALLY INDUCED DISORDER; NEWBORN DISEASE; PREGNANCY; PRENATAL EXPOSURE; REVIEW;

BIOLOGICAL MARKERS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SMOKING;

EID: 19044391766     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (84)

1. Yuksel B, Greenough A, Dobson P, Nicolaides KH. Advanced maternal age and smoking: risk factors for admission to a neonatal intensive care unit. J Perinat Med 1996; 24: 397-403.
2. Thorngren-Jerneck K, Herbst A. Low 5-minute Apgar score: a population-based register study of 1 million term births. Obstet Gynecol 2001; 98: 65-70.
3. Hoffman HJ, Damus K, Hillman L, Krongrad E. Risk factors for SIDS. Results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiological Study. Ann N Y Acad Sci. 1988; 533: 13-30.
4. Sherman J, Young A, Sherman MP, Collazo C, Bernert JT. Prenatal smoking and alterations in newborn heart rate during transition. J Obstet Gynecol Neonatal Nurs 2002; 31: 680-7.
5. Beratis NG, Panagoulias D, Varvarigou A. Increased blood pressure in neonates and infants whose mothers smoked during pregnancy. J Pediatr 1996; 128: 806-12.
6. Asmussen I. Fetal cardiovascular system as influenced by maternal smoking. Clin Cardiol 1979; 2: 246-56.
7. Maturri L, Lavezzi AM, Ottaviani G, Rossi L. Intimal preatherosclerotic thickening of the coronary arteries in human fetuses of smoker mothers. J Thromb Haemost 2003; 1: 2234-8.
8. Bearer C, Emerson RK, O'Riordan MA, Roitman E, Shackleton C. Maternal tobacco smoke exposure and persistant pulmonary hypertension of the newborn. Environ Health Perspect. 1997; 105: 202-6.
9. Lindqvist R, Lendahls L, Tollbom O, Aberg H, Hakansson A. Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women. Acta Obstet Gynecol Scand 2002; 81: 240-4.
10. Marin GH, Delgado L, Sager G, Visentin S, Azzaro S, Tozzi M. Consequences of smoking during pregnancy for mother and child. Rev Bras Saude Matern Infant 2003; 3: 159-164.
11. Beratis NG, Varvarigou A, Makri M, Vagenakis AG. Prolactin, growth hormone and insulin-like growth factor-I in newborn children of smoking mothers. Clin Endocrinol 1994; 40: 179-85.
12. Mantzoros CS, Varvarigou A, Kaklamani VG, Beratis NG, Flier JS. Effect of birth weight and maternal smoking on cord blood leptin concentrations of full-term and preterm newborns. J Clin Endocrinol Metab 1997; 82: 2856-61.
13. Bertelsen JB, Hegedus L. Cigarette smoking and the thyroid. Thyroid. Fall 1994; 4: 327-31.
14. Beratis NG, Varvarigou A, Christophidou M, Vassilakos P, Tsapanos V, Kourounis G. Cord blood alpha-fetoprotein concentrations in term newborns of smoking mothers. Eur J Pediatr 1999; 158: 583-8.
15. Bili H, Mamopoulos M, Tsantali C, Tzevelekis P, Malaka K, Mantalenakis S, et al. Elevated umbilical erythropoietin levels during labor in newborns of smoking mothers. Am J Perinatol 1996; 13: 85-7.
16. Varvarigou A, Beratis NG, Makri M, Vagenakis AG. Increased levels and positive correlation between erythropoietin and hemoglobin concentrations in newborn children of mothers who are smokers. J Pediatr 1994; 124: 480-2.
17. Henson MC, Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med 2004; 229: 383-92. Review.
18. Gomez C, Berlin I, Marquis P, Delcroix M. Expired air carbon monoxide concentration in mothers and their spouses above 5 ppm is associated with decreased fetal growth. Prev Med 2005; 40: 10-5.
19. Kallen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 2001; 11: 329-33.
20. Saxton DW. The behaviour of infants whose mothers smoke in pregnancy. Early Hum Dev 1978; 2: 363-9.
21. Picone TA, Allen LH, Olsen PN, Ferris ME. Pregnancy outcome in North American women. II. Effects of diet, cigarette smoking, stress, and weight gain on placentas, and on neonatal physical and behavioral characteristics. Am J Clin Nutr 1982; 36: 1214-24.
22. Sexton M, Fox NL, Hebel JR. Prenatal exposure to tobacco: II. Effects on cognitive functioning at age three. Int J Epidemiol 1990; 19: 72-7.
23. Eskenazi B, Castorina R. Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 1999; 107: 991-1000. Review.
24. Soothill PW, Ajayi RA, Campbell S, Ross EM, Nicolaides KH. Fetal oxygenation at cordocentesis, maternal smoking and childhood neuro-development. Eur J Obstet Gynecol Reprod Biol 1995; 59: 21-4.
25. Cornelius MD, Ryan CM, Day NL, Goldschmidt L, Willford JA. Prenatal tobacco effects on neuropsychological outcomes among preadolescents. J Dev Behav Pediatr 2001; 22: 217-25.
26. Fogelman KR, Manor O. Smoking in pregnancy and development into early adulthood. BMJ 1988; 297: 1233-6.
27. Fergusson DM, Horwood LJ, Lynskey MT. Maternal smoking before and after pregnancy: effects on behavioral outcomes in middle childhood. Pediatrics 1993; 92: 815-22.
28. Chen WJ, Parnell SE, West JR. Neonatal alcohol and nicotine exposure limits brain growth and depletes cerebellar Purkinje cells. Alcohol 1998; 15: 33-41.
29. Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J, Finnell RH. Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology 2004; 15: 150-6.
30. Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ. 2004; 82. 213-8. Epub 2004 Apr 16.
31. Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology 1996; 53: 261-7.
32. Dehaene P. La grossesse et l'alcool, Paris, PUF, « Que saisje ? » n° 2934, 1995.
33. Mennella JA, Beauchamp GK. Smoking and the flavor of breast milk. N Engl J Med 1998; 339: 1559-60.
34. Horta BL, Kramer MS, Platt RW. Maternal smoking and the risk of early weaning: a meta-analysis. Am J Public Health 2001; 91: 30.
35. British Medical Association. Smoking and reproductive life: The impact of smoking on sexual, reproductive and child health. BMA Publications, 2004.
36. Mello PR, Pinto GR, Botelho C. The influence of smoking on fertility, pregnancy and lactation] J Pediatr (Rio J) 2001; 77: 257-64.
37. Boshuizen HC, Verkerk PH, Reerink JD, Herngreen WP, Zaadstra BM, Verloove-Vanhorick SP. Maternal smoking during lactation: relation to growth during the first year of life in a Dutch birth cohort. Am J Epidemiol 1998; 147: 117-26.
38. Christen JA, Christen AG. The female smoker: from addiction to recovery. Indianapolis: Indiana University, 1998.
39. Schoendorf KC, Kiely JL. Relationship of sudden infant death syndrome to maternal smoking during and after pregnancy. Pediatrics 1992; 90: 905-8.
40. Schmeltz I, Hoffmann D. Nitrogen-containing compounds in tobacco smoke. Chem Rev 1977; 77: 295-311.
41. Burguet A, Berard M, Woronoff AS, Roth P, Menetrier M, Vanlemmens P et al. Appréciation du tabagisme maternel et néonatal par un dosage de la cotinine urinaire par chromatographie liquide haute performance. J Gynecol Obstet Biol Reprod 2001; 30: 166-73.
42. Pastrakuljic A, Schwartz R, Simone C, Derewlany LO, Knie B, Koren G. Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci 1998; 63: 2333-42.
43. Messina ES, Tyndale RF, Sellers EM. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997; 282: 1608-14.
44. rd, Benowitz NL. Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther 2000; 67: 458-65.
45. Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 1998; 71: 162-8.
46. Wang X, Tager IB, Van Vunakis H, Speizer FE, Hanrahan JP. Maternal smoking during pregnancy, urine cotinine concentrations, and birth outcomes. A prospective cohort study. Int J Epidemiol 1997; 26: 978-88.
47. Jacqz-Aigrain E, Zhang D, Maillard G, Luton D, Andre J, Oury JF. Maternal smoking during pregnancy and nicotine and cotinine concentrations in maternal and neonatal hair. BJOG 2002; 109: 909-11.
48. Kintz P, Kieffer I, Messer J, Mangin P. Nicotine analysis in neonates' hair for measuring gestational exposure to tobacco. J Forensic Sci 1993; 38: 119-23.
49. Klein J, Chitayat D, Koren G. Hair analysis as a marker for fetal exposure to maternal smoking. N Engl J Med 1993; 328: 66-7.
50. Eliopoulos C, Klein J, Phan MK, Knie B, Greenwald M, Chitayat D et al. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA 1994; 271: 621-3.
51. Eliopoulos C, Klein J, Chitayat D, Greenwald M, Koren G. Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking. Clin Invest Med 1996; 19: 231-42.
52. Jaakkola JJ, Jaakkola N, Zahlsen K. Fetal growth and length of gestation in relation to prenatal exposure to environmental tobacco smoke assessed by hair nicotine concentration. Environ Health Perspect 2001; 109: 557-61.
53. Ostrea EM Jr, Knapp DK, Romero A, Montes M, Ostrea AR. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J Pediatr 1994; 124: 471-6.
54. Derauf C, Katz AR, Easa D. Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters and cotinine. Am J Epidemiol 2003; 158: 705-9.
55. Baranowski J, Pochopien G, Baranowska I. Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998; 707: 317-21.
56. Burguet A, Berard M, Woronoff AS, Roth P, Menetrier M, Vanlemmens P, et al. Appréciation du tabagisme maternel et néonatal par un dosage de la cotinine urinaire par chromatographie liquide haute performance. J Gynecol Obstet Biol Reprod 2001; 30: 166-73.
57. Pichini S, Basagana XB, Pacifia R, Garcia O, Puig C, Vall O et al. Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ Health Perspect 2000; 108: 1079-83.
58. Nafstad P, Magnus P, Stray-Pedersen B. Opposing placental gradients for thiocyanate and cotinine at birth. Early Hum Dev 1995; 42: 73-79.
59. Nafstad P, Kongerud J, Botten G, Urdal P, Silsand T, Pedersen BS et al. Fetal exposure to tobacco smoke products: a comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum. Acta Ostet Gynecol Scand 1996; 75: 902-7.
60. Perkins SL, Belcher JM, Livesey JF. A Canadian tertiary care center study of maternal and umbilical cord cotinine levels as markers of smoking during pregnancy: relationship to neonatal effects. Can J Public Health 1997; 88: 232-7.
61. Jacob P 3rd, Yu L, Shulgin AT, Benowitz NL. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health 1999; 89: 731-6.
62. e édition mise à jour. Juin 2004. 127 pages. Presses Universitaires de France.
63. Donnenfeld AE, Pulkkinen A, Palomaki GE, Knight GJ, Haddow JE. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol 1993; 168: 781-2.
64. Hayde M, Bernaschek G, Stevenson DK, Knight GJ, Haddow JE, Widness JA. Antepartum fetal and maternal carboxyhemoglobin and cotinine levels among cigarette smokers. Acta Paediatr 1999; 88: 327-31.
65. Seidman DS, Paz I, Merlet-Aharoni I, Vreman H, Stevenson DK, Gale R. Noninvasive validation of tobacco smoke exposure in late pregnancy using end-tidal carbon monoxide measurements. J Perinatal 1999; 19: 358-61.
66. Seeker-Walker RH, Vacek PM, Flynn BS, Mead PB. Exhaled carbon monoxide and urinary cotinine as measures of smoking in pregnancy. Addict Behavior 1997; 22: 671-84.
67. Gomez C, Berlin I, Marquis P, Delcroix M. Expired air carbon monoxide concentration in mothers and their spouses above 5 ppm is associated with decreased fetal growth. Prev Med 2005; 40: 10-5.
68. Berlin I, Radzius A, Henningfield JE, Moolchan ET. Correlates of expired air carbon monoxide: effect of ethnicity and relationship with saliva cotinine and nicotine. Nicotine Tob Res 2001; 3: 325-31.
69. Beratis NG, Varvarigou A, Christophidou M, Vassilakos P, Tsapanos V, Kourounis G. Cord blood alpha-fetoprotein concentrations in term newborns of smoking mothers. Eur J Pediatr 1999; 158: 583-8.
70. Hogler W, Schmid A, Raber G, Solder E, Eibl G, Heinz-Erian P et al. Perinatal bone turnover in term human neonates and the influence of maternal smoking. Pediatr Res 2003; 53: 817-22.
71. Colak O, Alatas O, Aydogdu S, Uslu S. The effect of smoking on bone metabolism: maternal and cord blood bone marker levels. Clin Biochem 2002; 35: 247-50.
72. Pasanen M, Haaparanta T, Sundin M, Sivonen P, Vakakangas K, Raunio H et al. Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicology 1990; 62: 175-87.
73. Barnea ER. Modulatory effect of maternal serum on xenobiotic metabolizing activity of placental explants: modification by cigarette smoking. Hum Reprod 1994; 9: 1017-21.
74. Boden AG, Bush PG, Burke MD, Abramovich DR, Aggett P, Mayhew TM et al. Human placental cytochrome P450 and quinone reductase enzyme induction in relation to maternal smoking. Reprod Fertil Dev 1995; 7: 1521-4.
75. rd, Benowitz NL. Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther 2000; 67: 458-65.
76. Lin FJ, Fitzpatrick JW, Iannotti CA, Martin DS, Mariani BD, Tuan RS. Effects of cadmium on trophoblast calcium transport. Placenta 1997; 18: 341-56.
77. Piasek M, Blanusa M, Kostial K, Laskey JW. Placental cadmium and progesterone concentrations in cigarette smokers. Reprod Toxicol 2001; 15: 673-81.
78. Kuhnert BR, Kuhnert PM, Lazebnik N, Erhard P. The effect of maternal smoking on the relationship between maternal and fetal zinc status and infant birth weight. J Am Coll Nutr 1988; 7: 309-16.
79. Kuhnert BR, Kuhnert PM, Debanne S, Williams TG. The relationship between cadmium, zinc, and birth weight in pregnant women who smoke. Am J Obstet Gynecol 1987; 157: 1247.
80. Kuhnert PM, Kuhnert BR, Bottoms SF, Erhard P. Cadmiums levels in maternal blood, fetal cord blood, and placental tissues of pregnant women who smoke. Am J Obstet Gynecol 1982; 142: 1021-5.
81. Lazebnik N, Kuhnert BR, Kuhnert PM, Thompson KL. Zinc status, pregnancy complications, and labor abnormalities. Am J Obstet Gynecol 1988; 158: 181-6.
82. Kuhnert PM, Kuhnert BR, Erhard P, Brashear WT, Groh-Wargo SL, Webster S. The effect of smoking on placental and fetal zinc status. Am J Obstet Gynecol 1987; 157: 1241-6.
83. Kuhnert BR, Kuhnert PM, Zarlingo TJ. Associations between placental cadmium and zinc and age and parity in pregnant women who smoke. Obstet Gynecol 1988; 71: 67-70.
84. Larramendy C, Diviné C, Asfany-Farhang S, Lagrue G. Intérêts des différents marqueurs biologiques dans l'évaluation du tabagisme. Pathol Biol 2004; 52: 164-72.